• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

IgM levels in plasma predict outcome in severe pandemic influenza

tetano

Editor, Senior Moderator
J Clin Virol. 2013 Sep 18. pii: S1386-6532(13)00397-1. doi: 10.1016/j.jcv.2013.09.006. [Epub ahead of print]
IgM levels in plasma predict outcome in severe pandemic influenza.
Justel M, Socias L, Almansa R, Ram?rez P, Gallegos MC, Fernandez V, Gordon M, Andaluz-Ojeda D, Nogales L, Rojo S, Vall?s J, Estella A, Loza A, Le?n C, Lopez-Mestanza C, Blanco J, Berezo JA, Rosich S, Cill?niz C, Torres A, de Lejarazu RO, Martin-Loeches I, Bermejo-Martin JF.
Source

Servicio de Microbiolog?a, Hospital Cl?nico Universitario de Valladolid, SACYL, Avda Ram?n y Cajal 3, 47005 Valladolid, Spain(2).
Abstract
BACKGROUND:

Little is known on the participation of immunoglobulin isotypes and subclasses in the pathogenesis of the severe disease caused by the pandemic influenza virus (influenza A(H1N1)pdm09).
OBJECTIVES:

(1) To evaluate the association between plasma levels of IgG1, IgG2, IgG3, IgG4, IgA, IgM, IgE and outcome in patients with severe pandemic influenza. (2) To evaluate the association between immunoglobulin and cytokine levels in these patients.
STUDY DESIGN:

40 critically ill patients with community acquired pneumonia and influenza A(H1N1)pdm09 infection were recruited from November 2010 to February 2011. Plasma samples were collected during the first 24h following admission to the ICU. Immunoglobulins and 17 major cytokines were profiled in plasma.
RESULTS:

15 patients died (37.5%). When the association between clinical variables and prognosis was assessed, prior immunosuppression, APACHE II score, levels of IgG2 and levels of IgM were associated with outcome in a univariate Cox regression analysis. Kaplan Meier analysis showed that patients with levels of IgG2 and IgM<59 and<58mg/dl respectively died earlier. Multivariate Cox regression analysis showed that APACHE II score and levels of IgM were the best predictors of outcome, being levels of IgM a protective factor against mortality. IgM was the immunoglobulin showing the largest number of negative correlations with cytokine levels.
CONCLUSIONS:

Our results support a central role of IgM in preventing uncontrolled inflammatory response and mortality in severe pandemic influenza. Early assessment of IgM could contribute to guide clinical decisions in these patients.

Copyright ? 2013 Elsevier B.V. All rights reserved.
KEYWORDS:

CAP, COPD, Critical, Cytokines, HBP, ICU, Immunoglobulins, Influenza, Prognosis, chronic obstructive pulmonary disease, community acquired pneumonia, high blood pressure, intensive care unit

PMID:
24076102
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24076102
 
Back
Top Bottom